Your session is about to expire
← Back to Search
Blood Pressure Management Technology for High Blood Pressure
N/A
Recruiting
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-manage at least one hypertension medication
Age 65 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-months, 6-months
Awards & highlights
Study Summary
This trial will test a tech. system to help people manage their hypertension and see if it's effective. Participants get info. about hypertension and medications plus strategies for taking them. Mid- and post-assessments will measure outcomes.
Who is the study for?
This trial is for older adults aged 65 or over with high blood pressure who are not taking their hypertension medication as prescribed. Participants must be able to read and speak English, use an iPhone, manage at least one blood pressure medicine themselves, and commit to a six-month study period.Check my eligibility
What is being tested?
The trial tests two different blood pressure technology systems in people who struggle with medication adherence. All participants receive high blood pressure education; half also get strategies for managing medications. They're checked after three months and again at the end of the study.See study design
What are the potential side effects?
Since this trial focuses on technology systems rather than new medications, side effects are not a primary concern like they would be in drug trials. However, there may be indirect effects related to changes in how participants manage their existing hypertension treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I take medication for high blood pressure by myself.
Select...
I am 65 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3-months, 6-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-months, 6-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
adherence
Secondary outcome measures
mobile device proficiency
perceived autonomy
perceived competence
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Blood Pressure Technology System MExperimental Treatment1 Intervention
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Group II: Blood Pressure Technology System EExperimental Treatment1 Intervention
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
515 Previous Clinical Trials
148,490 Total Patients Enrolled
University of Illinois at Urbana-ChampaignOTHER
189 Previous Clinical Trials
37,161 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You didn't take your high blood pressure medicine at least 90% of the time for the last 2 weeks of the 4-week period when your medicine intake was monitored.I currently own and use an Apple iPhone.I take medication for high blood pressure by myself.I am 65 years old or older.Your vision is worse than 20/50 even with glasses or contacts.You have a high chance of having trouble with memory and thinking.I have severe depression, scoring over 11 on the GDS-15.
Research Study Groups:
This trial has the following groups:- Group 1: Blood Pressure Technology System M
- Group 2: Blood Pressure Technology System E
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current size of this medical experiment's participant pool?
"Affirmative. Clinicaltrials.gov indicates that this experiment, which was initially posted on November 2nd 2022, is recruiting participants at the present moment. For this trial to be successful, 224 individuals must enrol from two distinct sites."
Answered by AI
Are there any opportunities available to join this experiment?
"Clinicaltrials.gov reports this clinical study is currently looking for participants; the trial was initially posted on November 2nd 2022 and most recently modified on January 26th 2023."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger